Physician profile
Marek Piatek
NPI 1164426060
$1,268.10
in general payments reported to CMS, 2019-2025
19 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $62.26 · 2022: $208 · 2023: $288 · 2024: $93.82 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $493.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $312.68 | 2019-2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $264.62 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $153.75 | 2019-2023 | Lifevest |
| Boston Scientific Corporation | $93.82 | 2024 | Watchman |
| E.R. Squibb & Sons, L.L.C. | $79.55 | 2022-2023 | Camzyos |
| Edwards Lifesciences Corporation | $60.27 | 2019 | |
| Pfizer INC. | $43.70 | 2019-2023 | |
| Medtronic, INC. | $41.77 | 2025 | Selectsecure |
| Kowa Pharmaceuticals America, INC. | $34.94 | 2019 | |
| Sanofi-Aventis U.S. LLC | $31.19 | 2020-2023 | |
| Astrazeneca Pharmaceuticals LP | $27.09 | 2022-2023 | Farxiga |
| Bardy Diagnostics, INC. | $20.00 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $19.25 | 2019 | |
| Medtronic Vascular, INC. | $18.22 | 2020 | |
| Abbott Laboratories | $14.86 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $14.46 | 2023 | |
| Alkermes, INC. | $13.72 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.13 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marek Piatek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.